Research grants for Czech researchers

Horizon Europe Research Infrastructure programme calls open March 10 – June 16, 2026. Targets research infrastructure projects; EU consortium requirement applies. FCT coordinates Portuguese national participation. An EC info day was held March 18, 2026. Eligible entities include universities, research centres, and ERIC members.

International awards recognising outstanding contributions across multiple categories: Basic Sciences, Biology & Biomedicine, Climate Change & Environmental Sciences, Economics/Finance/Management, Humanities, ICT, Music & Opera, and Social Sciences. These are prizes for lifetime/career achievement rather than funded research grants.

Thematic multilateral call on neurodegenerative disorders under the EP BrainHealth partnership. Budget cap per call and/or proposal applies. Luxembourg partner must submit INTER application at both pre-proposal and full proposal stage via FNR online system. Thematic call — no bottom-up funding.

Thematic multilateral call under the ERDERA partnership (rare diseases). Budget cap per call and/or proposal applies. Luxembourg partner must submit INTER application at both pre-proposal and full proposal stage via FNR online system. Thematic call — no bottom-up funding.

Supports internationally mobile postdoctoral researchers; international mobility is a key requirement (host lab must be in a different country from PhD). Includes salary/stipend, relocation allowance, and childcare support. A host lab may support a maximum of one candidate per selection round. Open to researchers worldwide.

Early-career researchers across biomedical, clinical, population health, arts, humanities and social sciences. Administering organisation must submit by 15:00 GMT/BST on deadline day. Global Talent visa endorsement available for UK-based award holders. Applications open 4 March 2026.

Supports researchers at the career development stage across a broad range of disciplines (biomedical, clinical, social sciences, arts & humanities, data sciences). Applications managed in English via the Wellcome Funding platform; host organisation must administer the grant. Global eligibility; UK-hosted awardees may access Global Talent visa endorsement.

Career development award for researchers seeking to establish independence. Applications submitted via Wellcome Funding platform and approved by administering organisation by 15:00 BST deadline. Host organisation may be worldwide; UK-based hosts can support Global Talent visa endorsement. Covers clinical, epidemiological, qualitative, and basic research across multiple Discovery Advisory Group areas.

For early-career independent investigators (lab established 2018–2023) at non-profit academic/research institutions worldwide. MD, PhD or equivalent required. Single PI only; no co-investigators. Must have multi-year independent funding active in 2027. Proposed project must be distinct from the lab's main research portfolio. All materials must be submitted in English. Indirect costs capped at 10% of direct costs.

Open to postdoctoral researchers with <5 years mentored research experience (MD applicants exclude residency years). Must hold a doctoral degree by award activation. Research must be in immunology or cancer immunology. Fellowship may be conducted in the US or abroad at a non-profit institution. No citizenship restrictions. Only 1 fellow per sponsor per round.

Open to early-career researchers worldwide (no citizenship restrictions) with a doctoral degree and <5 years mentored research experience at award activation. Must be conducted at a non-profit institution (US or abroad). Supports hypothesis-driven basic or translational cancer immunology projects integrating computational biology/data science/genomics. Requires a faculty sponsor (assistant professor or higher) and a co-sponsor.

Open to postdoctoral researchers of any nationality with max 8 years post-PhD experience. European Fellowships require a host in an EU/associated country; Global Fellowships require EU/associated country nationals or long-term residents working in a third country then returning to Europe. Researchers must not have resided in the host country for more than 12 months in the last 3 years (standard MSCA mobility rule). Open to all scientific fields including Euratom research.

Postdoctoral fellowships for researchers of any nationality hosted at institutions in EU Member States or Associated Countries. Researchers must hold a PhD and have ≤8 years full-time research experience at the deadline. MSCA mobility rules apply: applicants cannot have resided in the host country for >12 months in the 3 years prior to the deadline. Full-time commitment required as a rule.

Postdoctoral fellowships for researchers of any nationality hosted at EU Member State or Associated Country institutions. Researchers must have a PhD and ≤8 years full-time research experience at deadline. Mobility rule applies: applicants cannot have resided/worked in the host country for >12 months in the 3 years before the deadline. Full-time employment required as a rule.

Open to postdoctoral researchers of any nationality with max 8 years post-PhD experience. European Fellowships: host in EU/Horizon Europe associated country. Global Fellowships: EU/associated country nationals or long-term residents, outgoing to third country then returning to Europe. Host organisations can be universities, research institutions, companies, SMEs, hospitals, NGOs, or public bodies. ERA Fellowship opt-in available for widening-country hosts.

Global Fellowships for nationals or long-term residents of EU Member States or Associated Countries, involving an outgoing phase at a non-EU/Associated Country partner and a mandatory return phase. Researchers must hold a PhD and have ≤8 years full-time research experience. MSCA mobility rules apply to both outgoing and return phases. Full-time commitment required as a rule.

Global Fellowships for nationals or long-term residents of EU Member States or Associated Countries, involving an outgoing phase at a non-EU/Associated Country host and a mandatory return phase. Researchers must have a PhD and ≤8 years full-time research experience at deadline. Mobility rule applies. Full-time employment required as a rule.

Postdoctoral researchers of any nationality, max 8 years full-time research experience post-PhD at deadline. Mobility rule applies: researcher must not have resided/worked in the host country for >12 months in the 3 years before deadline. Full-time commitment required. Host must be an eligible organisation in an EU Member State or Horizon Europe Associated Country.

Restricted to nationals or long-term residents of EU Member States or Horizon Europe Associated Countries, max 8 years post-PhD. Outgoing phase at a non-EU/non-Associated Country organisation, with mandatory return phase to an EU/Associated Country host. Full-time commitment required; mobility rules apply.

Open to PhD holders of any nationality. European Fellowships: any nationality, hosted in EU/Associated Country. Global Fellowships: European nationals or long-term residents, outgoing phase at a non-associated Third Country (e.g. Canada/Carleton), mandatory 12-month return phase to EU/Associated Country host. Supports inter-sectoral, interdisciplinary, and international mobility; also open to career-restart and conflict-displaced researchers.

Open to PhD holders of any nationality. European Fellowships: mobility to/within EU Member States or Horizon Europe Associated Countries. Global Fellowships: EU nationals or long-term residents, outgoing phase in non-associated Third Country + mandatory 12-month return phase to EU/Associated Country host. Applications submitted jointly by researcher and academic or non-academic host organisation. Specific Euratom conditions apply for nuclear research areas.

Horizon Europe RIA under the EU Cancer Mission supporting development of validated microbiome tools for early cancer prediction before disease onset, including AI risk modelling, longitudinal cohort studies, and comparison with liquid biopsy tests. Proposals must address multiple cancer types where possible and collaborate with large cohorts/registries. Lump sum grant; one grant expected.

Horizon Europe RIA under the Cancer Mission calling for development of advanced multiscale Virtual Human Twin (VHT) models integrating AI and multimodal patient data to understand cancer onset/progression and personalise treatments. Proposals must include multidisciplinary consortia (medical, AI, patient representatives, SMEs) and share data/models via UNCAN.eu and the Advanced VHT Platform under open science principles. Clinical studies may be included with a dedicated annex.

Horizon Europe RIA (lump sum) for academic investigator-initiated pragmatic clinical trials on immunotherapeutic interventions for refractory cancer patients. Proposals must include a clinical studies annex, disaggregate data by sex/gender/age, and engage patients in endpoint definition. Applicants must include diverse stakeholders and plan to join the EU Cancer Mission 'Diagnosis and Treatment' cluster. ~3 grants expected.

Horizon Europe RIA under the EU Cancer Mission call HORIZON-MISS-2026-02. One indicative grant of approximately €15M. Full topic description available in the Work Programme. Consortia must include eligible entities from at least 3 EU member states or associated countries.

Horizon Europe Innovation Action under the EU Cancer Mission call HORIZON-MISS-2026-02. One indicative grant of approximately €7M. Full topic description available in the Work Programme. Consortia must include eligible entities from at least 3 EU member states or associated countries.

Horizon Europe Coordination and Support Action under the EU Cancer Mission call HORIZON-MISS-2026-02. One indicative grant of approximately €5M. Full topic description available in the Work Programme. Consortia must include eligible entities from at least 3 EU member states or associated countries.

Horizon Europe Research and Innovation Action under the Cancer Mission 2026 call. Single grant expected at approximately €15M. Full topic description available in the call portal.

Horizon Europe RIA under the Cancer Mission. Requires development of multiscale AI-integrated Virtual Human Twins for cancer onset, progression and personalised treatment. Proposals must include clinical study annex if clinical studies are envisaged. Interdisciplinary consortia including healthcare professionals, patient representatives, AI experts and SMEs expected. Open science principles mandatory; data must be shared via UNCAN.eu and Advanced VHT Platform.

Horizon Europe RIA under the Cancer Mission (Supporting the implementation of the Cancer Mission call HORIZON-MISS-2026-02). Single grant expected. Full topic description available in the call portal.

Open to researchers at eligible organisations globally; lead applicant salary not covered unless based in a low- or middle-income country with a permanent/long-term contract requiring external salary recovery. Applications managed in English. Covers discovery research across a broad range of disciplines including sciences, arts, humanities, and social sciences.

For postdocs with a PhD in a biological discipline moving to a new country and new research area. Must be ≤3 years post-PhD at Full Proposal deadline (24 Sep 2026). Applicants cannot work in their country of nationality or PhD country. For-profit host institutions ineligible. 100% FTE required. Basic life sciences research only; applied/clinical projects excluded.

For postdocs with a PhD in a non-biological discipline (physics, chemistry, mathematics, engineering, computer science) with no/little life sciences experience, moving to a new country. Must be ≤3 years post-PhD at Full Proposal deadline. Cannot work in country of nationality or PhD country. For-profit host institutions ineligible. 100% FTE required. Basic life sciences research only.

Annual call for cancer research projects with Nordic collaboration. Total pool of €950,000. Applications submitted via NCU's own portal. Questions to ncu@kreftforeningen.no.

Annual call for cancer research projects with Nordic collaboration, funded by Nordic Cancer Union with Norwegian Cancer Society contributions. Total budget €950,000. Information and application portal on NCU's website. Questions to ncu@kreftforeningen.no.

Annual call for cancer research projects with Nordic collaboration. Norwegian Cancer Society contributes annually to the NCU partnership. Total 2026 envelope is €950,000. Application portal and full information on NCU website. Questions to ncu@kreftforeningen.no.

Annual call for cancer research projects with Nordic collaboration. Total budget €950,000. Applications submitted via NCU's own portal. Nordic cross-country collaboration is required.

Boehringer Ingelheim Fonds PhD Fellowship funds ambitious basic biomedical PhD projects. Europe-wide: EU citizens anywhere, or non-EU citizens whose PhD is at a European host. Experimental basic biomedical research only.

Bilateral project funding under the Weave procedure between SNSF (Switzerland) and GACR (Czech Republic). Applicants must be based at Swiss or Czech institutions. Max two simultaneous SNSF project grants allowed; one must be a Weave/Lead Agency project. Projects must start on the same date in both countries and run for the same duration (max 36 months).

Boehringer Ingelheim Fonds MD Fellowship funds medical students (primarily enrolled in Germany) for an experimental basic-biomedical research project in a leading lab away from their home institution.

Directly funded by the European Union and fully managed by the PRIMA Foundation. Supports transnational research and innovation projects among Mediterranean countries. Focuses on water management, agricultural systems, and the agri-food chain (water-energy-food-ecosystems nexus). Consortium of partners from Mediterranean/EU countries required.

EIC call (HORIZON-EIC-2026-PATHFINDERCHALLENGES-01): HORIZON EIC Grants

EIC call (HORIZON-EIC-2026-PATHFINDERCHALLENGES-01): HORIZON EIC Grants

EIC call (HORIZON-EIC-2026-PATHFINDERCHALLENGES-01): HORIZON EIC Grants

Open to laboratories, organisations, or collaborative projects focused on fighting blindness and visual impairment, primarily in developing regions, and/or developing innovations/new technologies for the visually impaired (odd-year focus). Candidates may span multiple disciplines or institutions. Award funds may be used for research, clinical practice, or public health programmes (no commercial use).

Branco Weiss Fellowship (Society in Science, administered by ETH Zurich) funds postdocs (PhD ≤5y, before first faculty post) pursuing independent, interdisciplinary research at any host institution worldwide. Not host-country-restricted.

Open to established researchers or teams led by an established researcher based at eligible not-for-profit organisations in the UK, Republic of Ireland, or low- and middle-income countries (excluding India and mainland China). Research must fit within Wellcome's Discovery Research remit and have potential to improve human life, health, and wellbeing across any discipline including STEM, humanities, social science, and public health.

Supports life scientists who have been independent group leaders for less than 4 years at time of application. Provides financial support for networking, training, lab member support, and mentoring for 4 years. Open to researchers in Europe and beyond (EMBC member states and associated countries).

MSCA call (HORIZON-MSCA-2027-COFUND-02): HORIZON TMA MSCA Cofund Postdoctoral programme

MSCA call (HORIZON-MSCA-2027-COFUND-01): HORIZON TMA MSCA Cofund Doctoral programme

Supports group leaders establishing new laboratories in participating countries (Croatia, Czechia, Estonia, Hungary, Lithuania, Luxembourg, Poland, Portugal, Türkiye) to strengthen life sciences there. Applicants must be moving to or recently established in one of these host countries. Grantees join the EMBO Young Investigator/Installation Grantee network.

Supports group leaders establishing new laboratories in participating countries (2026: Croatia, Czechia, Estonia, Hungary, Lithuania, Luxembourg, Poland, Portugal, Türkiye) to strengthen life sciences there. Applicants must be moving to or recently established in a host country within the scheme. Grantees join the EMBO Young Investigator/Installation Grantee international network.

MSCA call (HORIZON-MSCA-2027-SE-01): HORIZON TMA MSCA Staff Exchanges

MSCA call (HORIZON-MSCA-2027-CITIZENS-01): HORIZON Coordination and Support Actions

MSCA call (HORIZON-MSCA-2027-PF-01): HORIZON TMA MSCA Postdoctoral Fellowships - Global Fellowships

MSCA call (HORIZON-MSCA-2027-DN-01): HORIZON TMA MSCA Doctoral Networks

Funds research on early intervention for cognitive and functional outcomes in people experiencing or at risk of psychosis. Host organisations include universities, research institutes, non-academic healthcare orgs, NGOs, and companies worldwide (excluding mainland China). Lead applicant must contribute ≥20% research time. Lived experience involvement is mandatory. Phase III pharmacological trials and animal-model research are excluded.

Open to teams from higher education institutions, research institutes, non-academic healthcare organisations, not-for-profits, or companies worldwide (excluding mainland China). Focuses on anxiety and depression treatment research. Lead applicants based in UK or Republic of Ireland cannot claim their own salary. At least 20% research time commitment required from all applicants.

Open to multidisciplinary teams worldwide (excluding mainland China and sanctioned territories) from eligible organisations. Lead applicant must contribute ≥20% research time and hold a permanent/long-term contract. Must involve people with lived experience of anxiety, depression and/or psychosis. UK/Republic of Ireland leads cannot request salary. Overheads capped at 15–20% of direct costs.

Accelerates conversion of promising scientific discoveries into cancer therapeutics. Translational/drug discovery focus. Open to investigators at academic institutions globally. No explicit eligibility restrictions stated.

Climate and health research scheme. Applications submitted via Wellcome Grant Tracker and approved by administering organisation. Open access costs covered via block grant or supplementary funding. Fieldwork, engagement, and dissemination costs eligible. The full application deadline was July 2023 — this call appears to be closed.

Funds early-stage, pre-development technological innovations in cancer immunotherapy (not continuation of existing technologies). Applicants must hold a tenure-track position at a not-for-profit research institution. Co-PIs encouraged. Does not support clinical trials. Up to 10% indirect costs provided in addition to awarded funds. Proposals submitted in English.

Supports transdisciplinary teams to co-develop discovery research agendas at the intersection of genomics, humanities, social sciences and bioethics. Lead applicant must hold a PhD (or 4 years equivalent experience), have a permanent/long-term contract, and be based at an eligible non-commercial organisation anywhere in the world except mainland China. Commercial organisations ineligible as administering organisations.

Funds international exchange programmes in health-related humanities, social sciences, or bioethics. Lead applicant must be based at an eligible UK organisation; at least one co-applicant must be outside the UK (mainland China excluded). All applicants must hold permanent/open-ended contracts. High-income country organisations must demonstrate significant additional resource commitment.

Supports high-risk, high-reward cancer research (basic, translational, technology, clinical) worldwide. PIs must be independent researchers at their institutions. Indirect costs capped at 10% of direct costs. Clinical studies have higher budget/duration limits. Applications by invitation or RFP only.